Familial Mediterranean Fever in Japan

被引:97
|
作者
Migita, Kiyoshi [1 ]
Uehara, Ritei [4 ]
Nakamura, Yoshikazu [4 ]
Yasunami, Michio [2 ]
Tsuchiya-Suzuki, Ayako [5 ]
Yazaki, Masahide [5 ]
Nakamura, Akinori [5 ]
Masumoto, Junya [6 ]
Yachie, Akihiro [8 ]
Furukawa, Hiroshi [9 ]
Ishibashi, Hiromi [1 ]
Ida, Hiroaki [10 ]
Yamazaki, Kazuko [7 ]
Kawakami, Atsushi [3 ]
Agematsu, Kazunaga [7 ]
机构
[1] Nagasaki Med Ctr, Clin Res Ctr, Omura, Nagasaki, Japan
[2] Nagasaki Univ, Inst Trop Med NEKKEN, Nagasaki 852, Japan
[3] Nagasaki Univ Hosp, Dept Rheumatol, Nagasaki, Japan
[4] Jichi Med Univ, Dept Publ Hlth, Shimotsuke, Tochigi, Japan
[5] Shinshu Univ, Sch Med, Dept Med Neurol & Rheumatol, Matsumoto, Nagano 390, Japan
[6] Shinshu Univ, Sch Med, Dept Pathol, Matsumoto, Nagano 390, Japan
[7] Shinshu Univ, Sch Med, Dept Infect & Host Def, Matsumoto, Nagano 390, Japan
[8] Kanazawa Univ, Sch Med, Dept Pediat, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 920, Japan
[9] Natl Hosp Org, Sagamihara Natl Hosp, Clin Res Ctr, Sagamihara, Kanagawa, Japan
[10] Kurume Univ, Sch Med, Dept Rheumatol, Kurume, Fukuoka 830, Japan
关键词
GENOTYPE-PHENOTYPE; MEFV MUTATION; AMYLOIDOSIS; DISEASE; PREVALENCE; FMF; FREQUENCY; SPECTRUM; FEATURES; PATIENT;
D O I
10.1097/MD.0b013e318277cf75
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Familial Mediterranean fever (FMF) is a hereditary autoinflammatory disease that is prevalent in Mediterranean populations. While it is considered a rare disease in the rest of world, a significant number of FMF patients have been reported in East Asia, including Japan. Our aim was to determine the prevalence of FMF in Japan and elucidate the clinical and genetic features of Japanese patients. A primary nationwide survey of FMF was conducted between January and December 2009. Hospitals specializing in pediatrics and hospitals with pediatric, internal medicine, and rheumatology/allergy departments were asked to report all patients with FMF during the survey year. The estimated total number of Japanese FMF patients was 292 (95% confidence interval, 187-398 people). We evaluated the clinical and genetic profiles of Japanese patients from the data obtained in a secondary survey of 134 FMF patients. High-grade fever was observed in 95.5%, chest pain (pleuritis symptoms) in 36.9%, abdominal pain (peritonitis symptoms) in 62.7%, and arthritis in 31.3%. Of the patients profiled, 25.4% of patients experienced their first attack before 10 years of age, 37.3% in their teens, and 37.3% after age 20 years. Colchicine was effective in 91.8% of patients at a relatively low dose (mean dose, 0.89 +/- 0.45 mg/d). AA amyloidosis was confirmed in 5 patients (3.7%). Of the 126 patients studied, 109 (86.5%) were positive for 1 or more genetic mutations and 17 (13.5%) had no mutation detected. Common Mediterranean fever gene (MEFV) mutations were E148Q/M694I (19.8%) and M694I/normal (12.7%). The differences in the prevalence of peritonitis, pleuritis, and a family history of FMF were statistically significant between FMF patients with MEFV exon 10 mutations compared with those without exon 10 mutations. In conclusion, a significant number of patients with FMF exist in Japan. Although Japanese patients with FMF are clinically or genetically different from Mediterranean patients, the delay in diagnosis is an issue that should be resolved.
引用
收藏
页码:337 / 343
页数:7
相关论文
共 50 条
  • [21] Familial Mediterranean Fever with Onset at 66 Years of Age
    Inoue, Keita
    Torii, Kazuhiro
    Yoda, Aya
    Kadota, Koichiro
    Nakamichi, Seiko
    Obata, Yoko
    Nishino, Tomoya
    Migita, Kiyoshi
    Kawakami, Atsushi
    Ozono, Yoshiyuki
    INTERNAL MEDICINE, 2012, 51 (18) : 2649 - 2653
  • [22] MEFV heterogeneity in Turkish Familial Mediterranean Fever patients
    Papadopoulos, Vasileios
    Mitroulis, Ioannis
    Giaglis, Stavros
    MOLECULAR BIOLOGY REPORTS, 2010, 37 (01) : 355 - 358
  • [23] Renal involvement in familial Mediterranean fever in an Algerian population
    Khellaf, Ghalia
    Benziane, Ali
    Kaci, Louiza
    Ait-Idir, Djouher
    Missoum, Soumia
    Benabadji, Mohamed
    CLINICAL NEPHROLOGY, 2023, 99 (04) : 172 - 179
  • [24] Familial Mediterranean fever: different faces around the world
    Ben-Chetrit, E.
    Yazici, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (06) : 18 - 22
  • [25] MEFV mutations in patients with familial Mediterranean fever from the Aegean region of Turkey
    Akin, Haluk
    Onay, Huseyin
    Turker, Emre
    Cogulu, Ozgur
    Ozkinay, Ferda
    MOLECULAR BIOLOGY REPORTS, 2010, 37 (01) : 93 - 98
  • [26] Familial Mediterranean fever
    Aysin Bakkaloglu
    Pediatric Nephrology, 2003, 18 : 853 - 859
  • [27] Familial Mediterranean fever
    Bakkaloglu, A
    PEDIATRIC NEPHROLOGY, 2003, 18 (09) : 853 - 859
  • [28] Familial coexistence of demyelinating diseases and familial Mediterranean fever
    Korkmaz, Cengiz
    Uskudar Cansu, Dondu
    Kabay, Sibel Canbaz
    RHEUMATOLOGY INTERNATIONAL, 2022, 42 (01) : 167 - 173
  • [29] Familial Mediterranean fever
    Padeh, Shai
    Berkun, Yackov
    CURRENT OPINION IN RHEUMATOLOGY, 2016, 28 (05) : 523 - 529
  • [30] Familial Mediterranean Fever
    Baskin, Esra
    Saatci, Umit
    CURRENT RHEUMATOLOGY REVIEWS, 2006, 2 (01) : 101 - 108